CIMGOTCRetail-Miscellaneous RetailUS GAAP · USD

CIMG Inc.

CIMG Inc. is a Nevada-incorporated, Nasdaq-listed company that has shifted its identity from NuZee, Inc. to a broader digital marketing, distribution, and consumer-products platform. The company says it is using artificial intelligence, and in some cases blockchain-related technologies, to support brand management, user growth, and online sales. In 2024-2025 it also expanded into Asia-focused distribution and added Maca-infused food and beverage products, while introducing new revenue streams such as Computing Power Product Series and the Homology of Medicine and Food Series. The business is still in transition and appears to be building a more diversified consumer and technology-linked portfolio around online commerce, third-party distribution, and product commercialization.

Revenue10.3m USD
+433.5 %y/y
Operating profit (EBIT)-5.2m USD
+50.1 %y/y
EBIT margin-50.5%
+488.8 ppy/y
Net income-4.9m USD
+45.6 %y/y
Free cash flow-17.9m USD
−74.1 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-20-1001020m USD2020: 1.4 m USD2020: EBIT -9.3 m USD20202021: 1.9 m USD2021: EBIT -19 m USD20212022: 3.1 m USD2022: EBIT -11 m USD20222023: 3.3 m USD2023: EBIT -8.9 m USD20232024: 1.9 m USD2024: EBIT -10 m USD20242025: 10 m USD2025: EBIT -5.2 m USD202510-5.2
RevenueOperating profit (EBIT)

Business

Share of revenue
Maca Series products45 %

Maca-infused food and beverage products sold through the company's distribution and online channels.

Homology of Medicine and Food Series17 %

Functional consumer products positioned at the intersection of food and wellness.

Computing Power Product Series10 %

Newly introduced technology-linked product stream tied to computing power offerings.

Digital marketing and brand services8 %

Services and capabilities used to support user growth, brand management, and online commercialization.

Online distribution platform20 %

E-commerce and channel infrastructure used to market and distribute consumer products in Asia.

Products

Reported · share of revenue
99.4%FY2025100 %
  • Products99.4 %
  • Services0.6 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

CIMG's customers appear to be concentrated in a small number of commercial counterparties rather than a broad retail base. The company disclosed that its two largest customers accounted for about 96% of fiscal 2025 revenue, indicating that a handful of buyers or channel partners are critical to sales volume. The business also relies on brokers, distributors, common carriers, retailers, and third-party manufacturing partners to move products through its network, so customer demand is closely tied to channel execution. End demand is centered on consumer food and beverage products, especially Maca Series offerings, and on newer product lines that the company is trying to commercialize.

Large concentrated commercial customers

A very small number of customers generate most revenue and likely purchase in bulk or through distribution agreements.

Distributors and brokers

Buy or place products into downstream channels and are important because they determine market access and product turnover.

Retailers and common carriers

Handle last-mile availability and logistics for the company's consumer products, affecting sell-through and service levels.

Asia-focused consumer end markets

Consumers of Maca-infused and functional food-and-beverage products who buy for wellness, novelty, or brand appeal.

Technology and digital commerce counterparties

Customers or partners tied to the company's AI, blockchain, and computing-power initiatives as it broadens its revenue base.

Strategy

CIMG's stated strategy is to transform from a legacy consumer business into a broader digital marketing and distribution platform supported by AI and, where appropriate, blockchain-related technologies. A key priority is expanding sales and distribution channels in Asia, particularly for Maca-infused food and beverage products and related consumer offerings. The company is also trying to diversify beyond a narrow product set by introducing new revenue streams such as Computing Power Product Series and the Homology of Medicine and Food Series. This strategy matters because the company is highly concentrated in a few products, customers, and suppliers, so diversification is central to reducing execution risk and improving bargaining power.

Diversify product revenueShort term

The company is highly concentrated in Maca Series and related products, so new offerings are needed to reduce single-product dependence.

Expand Asia sales and distributionMedium term

Asia is the main growth geography disclosed in the reports and is central to scaling consumer product sales.

Improve digital commerce capabilitiesMedium term

AI-enabled search and digital marketing are intended to improve user acquisition, brand visibility, and conversion.

Reduce supply-chain and channel dependenceMedium term

The business relies heavily on third-party manufacturers, distributors, and retailers, so resilience depends on partner stability.

Geography

Q4/2025

CIMG is a U.S.-incorporated company listed on Nasdaq, but its commercial focus has increasingly shifted toward Asia. Management says it is expanding sales and distribution channels in Asia to cover a wider range of consumer food and beverage products, and it has also described an online sales platform designed to support that expansion. The company previously sold its Korean subsidiaries in 2024, which suggests its operating footprint has been in flux as it repositions the business. Because the business depends on third-party logistics, manufacturing, and distribution partners, geography matters not only for demand but also for supply-chain execution and regulatory exposure.

China100 %

Risks

CIMG faces substantial concentration risk because a very small number of customers and suppliers account for most of its revenue and purchases. The company also depends on third-party brokers, distributors, common carriers, and manufacturers, so operational performance can be disrupted by partner failures, pricing pressure, or supply interruptions. Its newer initiatives in AI, computing power, and digital assets add technology, cybersecurity, valuation, and regulatory uncertainty on top of the core consumer-products risks. More broadly, the business is exposed to changing consumer preferences, competition in wellness products, and cross-border execution risk as it expands in Asia.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Customer concentration1Supplier concentration2Product concentration in Maca Series3Third-party distribution and manufacturing dependence4Digital asset and AI-related uncertainty5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Customer concentrationImpact: CriticalLikelihood: Medium

    Two customers represented about 96% of fiscal 2025 revenue, so the loss or reduction of either customer would materially affect sales and cash flow.

    ExposureRevenueMarginsLiquidity
  2. Supplier concentrationImpact: CriticalLikelihood: Medium

    Two suppliers accounted for 96.76% of purchases, creating a major risk of shortages, delays, and pricing pressure.

    ExposureCost of goods soldInventory availability
  3. Product concentration in Maca SeriesImpact: HighLikelihood: Medium

    A large share of revenue comes from a narrow product set, so demand weakness or reputational issues would have an outsized impact.

    ExposureRevenue mixGross margin
  4. Third-party distribution and manufacturing dependenceImpact: HighLikelihood: Medium

    The company relies on external brokers, carriers, retailers, and manufacturers, so partner underperformance can interrupt sales.

    ExposureOperationsService levels
  5. Digital asset and AI-related uncertaintyImpact: MediumLikelihood: Medium

    Bitcoin holdings and AI-related initiatives introduce volatility, custody, cybersecurity, and regulatory risks.

    ExposureBalance sheetComplianceTechnology execution

Accounting

Judgemental items
Revenue recognition timing

Sales through distributors and retailers can create judgment around when control transfers and revenue is recorded.

Impact: Reported revenue and quarterly comparability

Digital asset valuation

Bitcoin holdings introduce fair value, custody, and potential impairment-related considerations.

Impact: Other income/expense and balance sheet volatility

Inventory valuation and obsolescence

Product concentration and changing demand can require write-downs if inventory cannot be sold at expected prices.

Impact: Gross margin and working capital

Estimates and assumptions under US GAAP

Management must estimate assets, liabilities, revenues, and expenses in a business undergoing transformation.

Impact: Earnings quality and comparability

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

CIMG Inc. (OTC) – Retail-Miscellaneous Retail | Financial Analysis – Clarifo